A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children

NCT07402512 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

498

Enrollment

OTHER

Sponsor class

Conditions

Respiratory Syncytial Virus Infection

Interventions

DRUG: SIM0916
DRUG: SIM0916 Placebo

Sponsor

Simcere Pharmaceutical Co., Ltd